Robin Reschke

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Robin Reschke

Apr 12, 2025, 16:44 | Science

Robin Reschke: Extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicities

Robin Reschke, Physician scientist at the University Hospital Heidelberg, shared a post on LinkedIn about a…

Jan 3, 2025, 12:51 | Science

Targeting Molecular Pathways to Control ICI Toxicities

John Gordon, VP Scientific Affairs, Co-Founder and Director at Celentyx Ltd, shared an article by…

Dec 29, 2024, 13:51 | Science

Targeting molecular pathways to control immune checkpoint inhibitor toxicities

Immune checkpoint blockade has revolutionized cancer treatment, offering the potential for durable responses. However, a…

Nov 10, 2024, 08:42 | Insight

Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin Syndrome

Dr. Robin Reschke and Prof. Jessica Hassel and colleagues from the National Center for Tumor…

Oct 8, 2024, 16:29 | Blog

Robin Reschke: Building Italian-German alliances at CCESumSchool24

Robin Reschke, Max-Eder Junior Research Group Leader at the National Center for Tumor Diseases (NCT)…

All: 5 Posts: 1 - 100

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

'

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

'

Bianca Balti: The Supermodel’s Brave Battle with Ovarian Cancer

'

NCD Frontlines with Saunthari Somasundaram | A New OncoDaily Podcast – Coming Soon

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023